Suchergebnisse - (Person:"Kim, Seong-Gon")

PubPharm (9)

1

Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation

enthalten in: Oncology reports | 2022

von Kang, Y. | Yang, W. | Chae, W. | +3

2

4-hexylresorcinol exerts antitumor effects via suppression of calcium oscillation and its antitumor effects are inhibited by calcium channel blockers

enthalten in: Oncology reports | 2013

von Kim, S. | Choi, J.

3

Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma

enthalten in: Oncology reports | 2012

von Kim, S. | Song, J.

4

4-hexylresorcinol stimulates the differentiation of SCC-9 cells through the suppression of E2F2, E2F3 and Sp3 expression and the promotion of Sp1 expression

enthalten in: Oncology reports | 2012

von Kim, S. | Kim, A. | Jeong, J. | +2

5

4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells

enthalten in: Oncology reports | 2011

von Kim, S. | Lee, S. | Park, Y. | +2

6

4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells

enthalten in: Oncology reports | 2011

von Kim, S. | Lee, S. | Park, Y. | +2

7

4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells

enthalten in: Oncology reports | 2011

von Kim, S. | Jeong, J. | Park, Y. | +4

8

4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells

enthalten in: Oncology reports | 2011

von Kim, S. | Jeong, J. | Park, Y. | +4

9

Recapitulating orthotopic tumor model through establishment of a parotid gland tumor with lung metastasis using HeLa cell injection into nude mice

enthalten in: Oncology reports | 2010

von Park, Y. | Kim, S. | Choi, J. | +1

1
[1]